X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (930) 930
Publication (155) 155
Book Chapter (13) 13
Book Review (11) 11
Conference Proceeding (9) 9
Newsletter (4) 4
Magazine Article (3) 3
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (704) 704
humans (666) 666
complement inhibitor eculizumab (293) 293
female (246) 246
eculizumab (240) 240
hematology (235) 235
complement (228) 228
male (217) 217
animals (196) 196
antibodies, monoclonal, humanized - therapeutic use (188) 188
immunology (177) 177
adult (164) 164
paroxysmal-nocturnal hemoglobinuria (152) 152
transplantation (148) 148
hemolytic-uremic syndrome (126) 126
middle aged (118) 118
activation (116) 116
paroxysmal nocturnal hemoglobinuria (115) 115
urology & nephrology (104) 104
treatment outcome (103) 103
care and treatment (101) 101
hemoglobinuria, paroxysmal - drug therapy (99) 99
complement c5 - antagonists & inhibitors (98) 98
thrombosis (98) 98
antibodies, monoclonal - therapeutic use (97) 97
complement activation (96) 96
disease (96) 96
diagnosis (93) 93
medicine, general & internal (86) 86
therapy (86) 86
natural-history (84) 84
pharmacology & pharmacy (82) 82
inhibitor eculizumab (81) 81
monoclonal antibodies (81) 81
aged (79) 79
analysis (79) 79
article (79) 79
immunosuppressive agents - therapeutic use (78) 78
proteins (78) 78
alternative pathway (77) 77
antibodies (76) 76
young adult (76) 76
hemolysis (75) 75
kidney transplantation (75) 75
thrombotic microangiopathy (75) 75
medicine & public health (72) 72
surgery (71) 71
health aspects (69) 69
research (69) 69
abridged index medicus (68) 68
atypical hemolytic uremic syndrome (67) 67
adolescent (66) 66
management (66) 66
antibodies, monoclonal, humanized (65) 65
inflammation (63) 63
complement activation - drug effects (62) 62
complement system proteins - immunology (62) 62
mice (62) 62
pregnancy (60) 60
antibody-mediated rejection (59) 59
oncology (59) 59
risk factors (59) 59
pnh (58) 58
rituximab (58) 58
anemia (57) 57
complement inhibitors (57) 57
hemoglobinuria, paroxysmal - diagnosis (57) 57
mutation (57) 57
kidneys (56) 56
complement inactivating agents - therapeutic use (55) 55
patients (55) 55
hemoglobinuria, paroxysmal - complications (54) 54
inhibitor (52) 52
review (52) 52
hemic and lymphatic diseases (47) 47
immunotherapy (47) 47
medicine, research & experimental (46) 46
drug therapy (45) 45
hemoglobinuria, paroxysmal - therapy (45) 45
nephrology (45) 45
child (44) 44
erythrocytes (42) 42
factor-h (42) 42
medicine (42) 42
renal-transplantation (42) 42
clinical trials (41) 41
thrombotic thrombocytopenic purpura (41) 41
recurrence (40) 40
viral antibodies (40) 40
hemoglobinuria, paroxysmal - immunology (39) 39
prognosis (39) 39
ahus (38) 38
antibodies, monoclonal, humanized - administration & dosage (38) 38
complement c5 - immunology (38) 38
hemoglobinuria, paroxysmal - blood (38) 38
internal medicine (38) 38
plasma exchange (38) 38
biochemistry & molecular biology (37) 37
calcineurin inhibitors (37) 37
macular degeneration (37) 37
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (917) 917
German (7) 7
Spanish (7) 7
French (6) 6
Japanese (5) 5
Italian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Reviews Drug Discovery, ISSN 1474-1776, 07/2007, Volume 6, Issue 7, pp. 515 - 516
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 14, pp. 1377 - 1380
To the Editor: With regard to the article by Legendre et al. (June 6 issue) 1 : assessment of the 37 patients with atypical hemolytic–uremic syndrome is... 
EQ-5D | MEDICINE, GENERAL & INTERNAL | Antibodies, Monoclonal, Humanized - therapeutic use | Humans | Female | Male | Thrombotic Microangiopathies - prevention & control | Complement C5 - antagonists & inhibitors | Hemolytic-Uremic Syndrome - drug therapy | Renal function
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2013, Volume 368, Issue 23, pp. 2169 - 2181
Journal Article
Blood, ISSN 0006-4971, 02/2017, Volume 129, Issue 8, pp. 922 - 923
In this issue of Blood, Harder et al demonstrate that breakthrough hemolysis in patients with paroxysmal nocturnal hemoglobinuria (PNH) treated with eculizumab... 
COMPLEMENT | PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA | INHIBITOR | HEMATOLOGY
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2009, Volume 360, Issue 5, pp. 544 - 546
Journal Article
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2014, Volume 20, Issue 4, pp. 518 - 525
Abstract We recently observed that dysregulation of the complement system may be involved in the pathogenesis of hematopoietic stem cell... 
Hematology, Oncology and Palliative Medicine | Hematopoietic stem cell transplant | Eculizumab | Thrombotic microangiopathy | Eculizumab pharmacokinetics | CH50 | DIAGNOSIS | LONG-TERM SURVIVORS | COMPLEMENT | HEMOLYTIC-UREMIC SYNDROME | IMMUNOLOGY | TRANSPLANTATION | GLOMERULAR-FILTRATION-RATE | Hematopoietic stem cell | CYSTATIN-C | transplant | Eculizumab pharrnacokinetics | CHRONIC KIDNEY-DISEASE | HYPERTENSION | HEMATOLOGY | CHSO | Hematologic Neoplasms - therapy | Severity of Illness Index | Complement Hemolytic Activity Assay | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Hematologic Neoplasms - mortality | Humans | Child, Preschool | Complement Membrane Attack Complex - antagonists & inhibitors | Thrombotic Microangiopathies - mortality | Transplantation, Autologous | Hematologic Neoplasms - pathology | Transplantation, Homologous | Drug Dosage Calculations | Complement Inactivating Agents - therapeutic use | Hematopoietic Stem Cell Transplantation - adverse effects | Survival Analysis | Hematologic Neoplasms - immunology | Thrombotic Microangiopathies - etiology | Drug Monitoring | Child | Thrombotic Microangiopathies - immunology | Thrombotic Microangiopathies - drug therapy | Hypertension | Enzymes | Mortality | Stem cells | Transplantation | Children | Health aspects | Hematopoietic stem cells
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2015, Volume 373, Issue 11, pp. 1032 - 1039
Journal Article
Journal Article